Unknown

Dataset Information

0

Impact of age on cardiovascular drug use in patients with chronic kidney disease.


ABSTRACT: Background:Elderly patients with chronic kidney disease (CKD) are often excluded from clinical trials; this may affect their use of essential drugs for cardiovascular complications. We sought to assess the impact of age on cardiovascular drug use in elderly patients with CKD. Methods:We used baseline data from the Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort including 3033 adult patients with CKD Stages 3 and 4. We studied the use of recommended drugs for coronary artery disease (CAD), stroke and atrial fibrillation by age, after adjusting for socio-demographic and clinical conditions. Results:The patients' mean age was 66.8?years (mean estimated glomerular filtration rate 32.9?mL/min/1.73?m2). The prevalence of CAD was 24.5% [81.3% receiving antiplatelet agents, 75.6% renin-angiotensin system (RAS) blockers, 65.4% ?-blockers and 81.3% lipid-lowering therapy], that of stroke 10.0% (88.8% receiving antithrombotic drugs) and that of atrial fibrillation 11.1% (69.5% receiving oral anticoagulants). Compared with patients aged <65 years, older age (?65?years) was associated with greater use of antithrombotic drugs in stroke [adjusted odds ratio (aOR) (95% confidence interval)?=?2.83 (1.04-7.73) for patients aged (75-84 years)] and less use of RAS blockers [aOR?=?0.39 (0.16-0.89) for patients aged ?85 years], ?-blockers [aOR?=?0.31 (0.19-0.53) for patients aged 75-84 years] and lipid-lowering therapy [aOR?=?0.39 (0.15-1.02) for patients aged ?85 years, P for trend?=?0.01] in CAD. Older age was not associated with less use of antiplatelet agents in CAD or oral anticoagulants in atrial fibrillation. Conclusions:In patients with CKD, older age per se was not associated with the underuse of antithrombotic drugs but was for other major drugs, with a potential impact on cardiovascular outcomes.

SUBMITTER: Villain C 

PROVIDER: S-EPMC7147308 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Elderly patients with chronic kidney disease (CKD) are often excluded from clinical trials; this may affect their use of essential drugs for cardiovascular complications. We sought to assess the impact of age on cardiovascular drug use in elderly patients with CKD.<h4>Methods</h4>We used baseline data from the Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort including 3033 adult patients with CKD Stages 3 and 4. We studied the use of recommen  ...[more]

Similar Datasets

| S-EPMC7995703 | biostudies-literature
| S-EPMC9869852 | biostudies-literature
| S-EPMC5133395 | biostudies-literature
| S-EPMC2100430 | biostudies-other
| S-EPMC8685353 | biostudies-literature
| S-EPMC5428576 | biostudies-literature
| S-EPMC9351620 | biostudies-literature
| S-EPMC5794851 | biostudies-other
| S-EPMC6280192 | biostudies-literature
| S-EPMC6027904 | biostudies-literature